These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22246516)

  • 1. No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda.
    Horwitz RH; Tsai AC; Maling S; Bajunirwe F; Haberer JE; Emenyonu N; Muzoora C; Hunt PW; Martin JN; Bangsberg DR
    AIDS Behav; 2013 Jan; 17(1):260-5. PubMed ID: 22246516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.
    Venkataramani AS; Thirumurthy H; Haberer JE; Ii YB; Siedner MJ; Kembabazi A; Hunt PW; Martin JN; Bangsberg DR; Tsai AC
    AIDS; 2014 May; 28(8):1221-6. PubMed ID: 24406678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.
    Nash D; Wu Y; Elul B; Hoos D; El Sadr W;
    AIDS; 2011 Jul; 25(12):1523-33. PubMed ID: 21750418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of pre-antiretroviral care and competition from traditional healers, crucial risk factors for very late initiation of antiretroviral therapy for HIV--a case-control study from eastern Uganda.
    Muhamadi L; Tumwesigye NM; Kadobera D; Marrone G; Wabwire-Mangen F; Pariyo G; Peterson S; Ekström AM
    Pan Afr Med J; 2011; 8():40. PubMed ID: 22121448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda.
    Weiser SD; Palar K; Frongillo EA; Tsai AC; Kumbakumba E; Depee S; Hunt PW; Ragland K; Martin J; Bangsberg DR
    AIDS; 2014 Jan; 28(1):115-20. PubMed ID: 23939234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.
    Peltzer K; Ramlagan S; Khan MS; Gaede B
    SAHARA J; 2011; 8(4):179-86. PubMed ID: 23236959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
    Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
    PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.
    Mermin J; Ekwaru JP; Were W; Degerman R; Bunnell R; Kaharuza F; Downing R; Coutinho A; Solberg P; Alexander LN; Tappero J; Campbell J; Moore DM
    BMJ; 2011 Nov; 343():d6792. PubMed ID: 22074711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.
    Mills EJ; Bakanda C; Birungi J; Mwesigwa R; Chan K; Ford N; Hogg RS; Cooper C
    AIDS; 2011 Mar; 25(6):851-5. PubMed ID: 21330903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.
    Kipp W; Alibhai A; Saunders LD; Senthilselvan A; Kaler A; Konde-Lule J; Okech-Ojony J; Rubaale T
    AIDS Care; 2010 Mar; 22(3):271-8. PubMed ID: 20390506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda.
    Bajunirwe F; Tisch DJ; King CH; Arts EJ; Debanne SM; Sethi AK
    AIDS Care; 2009 Mar; 21(3):271-9. PubMed ID: 19280404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persons living with HIV infection on antiretroviral therapy also consulting traditional healers: a study in three African countries.
    Wanyama JN; Tsui S; Kwok C; Wanyenze RK; Denison JA; Koole O; van Praag E; Castelnuovo B; Wabwire-Mangen F; Kwesigabo GP; Colebunders R
    Int J STD AIDS; 2017 Sep; 28(10):1018-1027. PubMed ID: 28162034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study.
    Wakeham K; Harding R; Levin J; Parkes-Ratanshi R; Kamali A; Lalloo DG
    BMC Palliat Care; 2017 Jul; 17(1):8. PubMed ID: 28705181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
    Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
    HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.
    Haberer JE; Musinguzi N; Boum Y; Siedner MJ; Mocello AR; Hunt PW; Martin JN; Bangsberg DR
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):386-92. PubMed ID: 26110445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project.
    Okoboi S; Ekwaru PJ; Campbell JD; Egessa A; King R; Bakanda C; Muramuzi E; Kaharuza F; Malamba S; Moore DM
    BMC Public Health; 2016 Feb; 16():101. PubMed ID: 26830678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to antiretroviral initiation in HIV-1-discordant couples.
    Guthrie BL; Choi RY; Liu AY; Mackelprang RD; Rositch AF; Bosire R; Manyara L; Gatuguta A; Kiarie JN; Farquhar C
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):e87-93. PubMed ID: 21826010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.